In drug development, QALY is used to evaluate the potential impact of new cancer drugs. Pharmaceutical companies conduct clinical trials to gather data on the effectiveness and side effects of new treatments, which is then used to calculate QALY. This information is critical for gaining regulatory approval and for negotiating pricing and reimbursement with healthcare payers.
